ClinicalTrials.gov record
Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
ClinicalTrials.gov ID: NCT00524030
Public ClinicalTrials.gov record NCT00524030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 4, 2026, 3:20 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Multicenter Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
Study identification
- NCT ID
- NCT00524030
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 161 participants
Conditions and interventions
Conditions
Interventions
- pregabalin 150 mg/day Drug
- pregabalin 600 mg/day Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2007
- Primary completion
- Mar 31, 2011
- Completion
- May 31, 2011
- Last update posted
- Jan 19, 2021
2007 – 2011
United States locations
- U.S. sites
- 63
- U.S. states
- 26
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Northport | Alabama | 35476 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85003 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85013 | — |
| Pfizer Investigational Site | Sun City | Arizona | 85351 | — |
| Pfizer Investigational Site | Fayetteville | Arkansas | 72703 | — |
| Pfizer Investigational Site | Fullerton | California | 92835 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Modesto | California | 95355 | — |
| Pfizer Investigational Site | Murrieta | California | 92562 | — |
| Pfizer Investigational Site | Newport Beach | California | 92660 | — |
| Pfizer Investigational Site | Temecula | California | 92591 | — |
| Pfizer Investigational Site | Denver | Colorado | 80204 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32209 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32901 | — |
| Pfizer Investigational Site | Miami | Florida | 33126 | — |
| Pfizer Investigational Site | Miami | Florida | 33136 | — |
| Pfizer Investigational Site | Sarasota | Florida | 34232 | — |
| Pfizer Investigational Site | Sarasota | Florida | 34233 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Lawrenceville | Georgia | 30045 | — |
| Pfizer Investigational Site | Suwanee | Georgia | 30024 | — |
| Pfizer Investigational Site | Anderson | Indiana | 46016 | — |
| Pfizer Investigational Site | Danville | Indiana | 46122 | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | 46805 | — |
| Pfizer Investigational Site | Kansas City | Kansas | 66160 | — |
| Pfizer Investigational Site | Bowling Green | Kentucky | 42101 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40536-0284 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40536 | — |
| Pfizer Investigational Site | Houma | Louisiana | 70363 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71105-5634 | — |
| Pfizer Investigational Site | Pikesville | Maryland | 21208 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01605 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01608 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48202 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55422 | — |
| Pfizer Investigational Site | Flowood | Mississippi | 39232 | — |
| Pfizer Investigational Site | Hattiesburg | Mississippi | 39401-7246 | — |
| Pfizer Investigational Site | Great Falls | Montana | 59405 | — |
| Pfizer Investigational Site | Cedarhurst | New York | 11516 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28207 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28209 | — |
| Pfizer Investigational Site | Rocky Mount | North Carolina | 27804 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44195 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210-1250 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16602 | — |
| Pfizer Investigational Site | Indiana | Pennsylvania | 15701 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38163 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37232 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Houston | Texas | 77074-2906 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78258 | — |
| Pfizer Investigational Site | Temple | Texas | 76508 | — |
| Pfizer Investigational Site | Murray | Utah | 84107 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84107 | — |
| Pfizer Investigational Site | West Jordan | Utah | 84088 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00524030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2021 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00524030 live on ClinicalTrials.gov.